VIRGINIA RETIREMENT SYSTEMS ET Al Buys Shares of 22,133 Lantheus Holdings, Inc. $LNTH

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 22,133 shares of the medical equipment provider’s stock, valued at approximately $1,812,000.

Other large investors have also bought and sold shares of the company. State of Michigan Retirement System grew its holdings in shares of Lantheus by 0.6% in the 1st quarter. State of Michigan Retirement System now owns 16,600 shares of the medical equipment provider’s stock valued at $1,620,000 after buying an additional 100 shares during the period. Signaturefd LLC lifted its holdings in Lantheus by 36.5% during the first quarter. Signaturefd LLC now owns 434 shares of the medical equipment provider’s stock worth $42,000 after acquiring an additional 116 shares in the last quarter. Intrust Bank NA grew its stake in Lantheus by 2.9% in the first quarter. Intrust Bank NA now owns 4,417 shares of the medical equipment provider’s stock valued at $431,000 after acquiring an additional 125 shares during the period. Focus Financial Network Inc. increased its holdings in shares of Lantheus by 4.0% in the second quarter. Focus Financial Network Inc. now owns 3,576 shares of the medical equipment provider’s stock worth $293,000 after acquiring an additional 136 shares in the last quarter. Finally, Nisa Investment Advisors LLC raised its position in shares of Lantheus by 2.1% during the first quarter. Nisa Investment Advisors LLC now owns 6,691 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 139 shares during the period. 99.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. TD Cowen decreased their price objective on Lantheus from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Monday, September 15th. B. Riley reduced their price target on shares of Lantheus from $109.00 to $84.00 and set a “buy” rating for the company in a report on Tuesday, September 16th. William Blair restated a “market perform” rating on shares of Lantheus in a report on Wednesday, July 16th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Lantheus in a research report on Wednesday, October 8th. Finally, Mizuho lowered their target price on Lantheus from $120.00 to $70.00 and set an “outperform” rating for the company in a report on Thursday, August 7th. Four investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, Lantheus currently has an average rating of “Moderate Buy” and an average target price of $74.50.

Insider Activity

In other Lantheus news, insider Farallon Partners L. L. C/Ca sold 3,365,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $56.15, for a total transaction of $188,944,750.00. Following the transaction, the insider owned 3,477,227 shares of the company’s stock, valued at $195,246,296.05. The trade was a 49.18% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Rajiv A. Patel sold 3,365,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $56.15, for a total value of $188,944,750.00. Following the sale, the insider owned 3,477,227 shares in the company, valued at approximately $195,246,296.05. This represents a 49.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,812,000 shares of company stock worth $382,427,380 in the last quarter. 1.50% of the stock is currently owned by corporate insiders.

Lantheus Stock Performance

Shares of LNTH opened at $57.13 on Thursday. The stock has a market capitalization of $3.88 billion, a price-to-earnings ratio of 15.19 and a beta of 0.09. Lantheus Holdings, Inc. has a 12 month low of $47.25 and a 12 month high of $118.21. The firm has a fifty day simple moving average of $54.06 and a 200 day simple moving average of $72.51. The company has a current ratio of 4.29, a quick ratio of 4.07 and a debt-to-equity ratio of 0.49.

Lantheus (NASDAQ:LNTH) last issued its quarterly earnings results on Tuesday, May 17th. The medical equipment provider reported $0.05 earnings per share (EPS) for the quarter. Lantheus had a net margin of 17.82% and a return on equity of 34.06%. The firm had revenue of $92.51 million for the quarter. Research analysts forecast that Lantheus Holdings, Inc. will post 6.01 EPS for the current fiscal year.

About Lantheus

Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer.